Cardiac Pathways Overview

  • Founded
  • 1991
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $115M
Latest Deal Amount

Cardiac Pathways General Information

Description

Provider of invasive systems used by electrophysiologists to diagnose and treat abnormally rapid heart rhythms. The company's products consist of systems for performing nonsurgical, minimally invasive techniques for neutralizing heart tissues responsible for starting tachyarrhythmia.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Acquirer
Boston Scientific
Primary Office
  • 995 Benecia Avenue
  • Sunnyvale, CA 94085
  • United States
+1 (408) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardiac Pathways Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 06-Aug-2001 $115M 00000 00000 Completed Generating Revenue
8. PIPE 26-Dec-2000 000.00 00000 Completed Generating Revenue
7. IPO 14-Jun-1996 000.00 000.00 00000 Completed Startup
6. Later Stage VC (Series F) 01-Dec-1995 000.00 000.00 000.00 Completed Startup
5. Later Stage VC (Series E) 16-May-1994 00.00 0000 000.00 Completed Startup
4. Later Stage VC (Series D) 29-Oct-1993 0000 000.00 000.00 Completed Startup
3. Later Stage VC (Series C) 00.000 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) $3.41M $3.94M 00.000 Completed Startup
1. Early Stage VC (Series A) $533K $533K 00.000 Completed Startup
To view Cardiac Pathways’s complete valuation and funding history, request access »

Cardiac Pathways Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series F 000,000 00.000000 00.0 000 000 00 000 00.000
Series E 000,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series D 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.00
Series C 0,000,000 00.000000 00.00 00 00 00 00 00.000
Series B 1,514,445 $0.001000 $0.18 $2.25 $2.25 1x $2.25 23.02%
Series A 716,667 $0.001000 $0.06 $0.75 $0.75 1x $0.75 10.79%
To view Cardiac Pathways’s complete cap table history, request access »

Cardiac Pathways Patents

Cardiac Pathways Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-5997532-A Ablation catheter tip with a buffer layer covering the electrode Expired - Fee Related 03-Jul-1997 00000000000 00
US-5813991-A Endocardial mapping system and method Expired - Fee Related 25-Apr-1997 00000000 00
US-5906605-A For use in mapping the wall of a heart of a patient Expired - Fee Related 10-Jan-1997 0000000000 00
US-5820568-A Apparatus and method for aiding in the positioning of a catheter Expired - Fee Related 15-Oct-1996 0000000000 000
US-6119041-A Apparatus and method for linear lesion ablation Expired - Lifetime 06-Mar-1996 A61B17/00234 00
To view Cardiac Pathways’s complete patent history, request access »

Cardiac Pathways Executive Team (3)

Name Title Board Seat Contact Info
Joseph Gorman Chief Investment Officer
Mir Imran Founder & Director
You’re viewing 2 of 3 executive team members. Get the full list »

Cardiac Pathways Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Delphi Ventures Venture Capital Minority 000 0000 000000 0
Faria Fund Minority 000 0000 000000 0
Fogarty Family Revocable Trust Minority 000 0000 000000 0
IVP Venture Capital Minority 000 0000 000000 0
MedVenture Associates Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »